A formidable type of childhood cancer gets added to highly regarded library of treatment recommendations
Business Announcement
Updates every hour. Last Updated: 20-Oct-2026 10:16 ET (20-Oct-2026 14:16 GMT/UTC)
For women who lose part of their clitoris because of vulvar cancer, a clitoral reconstruction procedure has now been developed for the first time. This comes forty years after the first penile reconstruction surgery. Results in the initial group of patients are encouraging.
The Southern California Environmental Health Sciences Center (SCEHSC) has received an $8 million grant from the National Institutes of Health (NIH) to advance research on the health effects of environmental exposures. SCEHSC, which is based at the Keck School of Medicine of USC and has been continuously funded by NIH for more than 30 years. The center has supported research on air pollution that has been highly influential in development of regulatory standards, on extreme heat and wildfires, per- and polyfluoroalkyl substances (PFAS) and on environmental effects on cardiorespiratory health, neurodevelopment and cognitive aging, kidney, liver and metabolic disease, and diabetes. The new grant ensures the center can continue backing these and other efforts through pilot funding, service cores providing expertise in exposure assessment, study design, biostatistics and data science, community engagement, research translation and science communication, and additional resources. Central to SCEHSC’s impact is its pilot program, which provides funding and support to help investigators turn promising ideas into established research programs. The program has generated a 30-to-1 return on its investments, with pilot funding helping researchers attract additional support, primarily from NIH. The new NIH funding will also allow SCEHSC to expand its work in two new areas in environmental health: artificial intelligence (AI) and cancer. SCEHSC is also expanding its work on environmental exposures linked to cancer in children and adults, in collaboration with the USC Norris Comprehensive Cancer Center.
One of the major challenges in the treatment of the most common subtype of breast cancer (hormone receptor positive, HR+) is the emergence of resistance. In new research published today in Science Advances, Boston Children’s Hospital researchers and colleagues have discovered a new driver of resistance in this cancer, introducing a new direction for early diagnosis of the resistant cancer cells, and a possible path to target them.